Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Rectal Neoplasms and ERCC2[original query] |
---|
Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. Pharmacogenomics 2010 Jun 11 (6): 747-61. Balboa Emilia, Duran Goretti, Lamas Maria Jesus, Gomez-Caamaño Antonio, Celeiro-Muñoz Catuxa, Lopez Rafael, Carracedo Angel, Barros Francis |
Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Scientific reports 2014 4 4112. Ni Min, Zhang Wei-zhong, Qiu Jin-rong, Liu Fei, Li Min, Zhang Ya-jie, Liu Qing, Bai J |
DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2015 16 (2): 713-8. Guo Cheng-Xian, Yang Guo-Ping, Pei Qi, Yin Ji-Ye, Tan Hong-Yi, Yuan Ho |
Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial. International journal of cancer 2019 May . Boige Valérie, Mollevi Caroline, Gourgou Sophie, Azria David, Seitz Jean-François, Vincent Marc, Bigot Ludovic, Juzyna Beata, Miran Isabelle, Gerard Jean-Pierre, Laurent-Puig Pier |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: